Bulletin
Investor Alert

press release

Aug. 4, 2021, 8:01 a.m. EDT

Pacira BioSciences to Present at the 2021 Wedbush PacGrow Healthcare Virtual Conference

PARSIPPANY, N.J., Aug 04, 2021 (GLOBE NEWSWIRE via COMTEX) -- PARSIPPANY, N.J., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. /zigman2/quotes/202929053/composite PCRX -0.96% today announced that it will present at the 2021 Wedbush PacGrow Healthcare Virtual Conference at 10:20 AM ET on Tuesday, August 10, 2021. Live audio of the virtual event can be accessed by visiting the "Events" page of the company's website at investor.pacira.com . A replay of the webcast will also be available for two weeks following the event.

About Pacira

Pacira BioSciences, Inc. /zigman2/quotes/202929053/composite PCRX -0.96% is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients' journeys along the neural pain pathway. The company's long-acting local analgesic, EXPAREL(R) (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam(R), a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera�(R) system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com .








        Company Contact:
        Pacira BioSciences, Inc.
        Christian Pedetti
        (973) 254-4387
        Christian.pedetti@pacira.com
        


COMTEX_390921415/2471/2021-08-04T08:00:32

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

(C) Copyright 2021 GlobeNewswire, Inc. All rights reserved.

/zigman2/quotes/202929053/composite
US : U.S.: Nasdaq
$ 52.61
-0.51 -0.96%
Volume: 208,108
Oct. 22, 2021 4:00p
P/E Ratio
13.46
Dividend Yield
N/A
Market Cap
$2.34 billion
Rev. per Employee
$688,537
loading...
/zigman2/quotes/202929053/composite
US : U.S.: Nasdaq
$ 52.61
-0.51 -0.96%
Volume: 208,108
Oct. 22, 2021 4:00p
P/E Ratio
13.46
Dividend Yield
N/A
Market Cap
$2.34 billion
Rev. per Employee
$688,537
loading...

Partner Center

Link to MarketWatch's Slice.